More than 1,600 Risperdal injury claims are currently pending in Philadelphia court, all of which allege the antipsychotic drug caused female breast tissue development in young men. The first three trials have concluded in massive wins for the injured plaintiffs. Our Risperdal attorneys are currently representing young men who developed gynecomastia from this drug. Gynecomastia …
When Hospitals and Big Pharma Commit Fraud
Healthcare fraud costs the U.S. tens of billions of dollars every year. It is a type of white-collar crime that involves filing dishonest or false billings to the government (through Medicare, for example). This can take many forms, which is why it is so difficult to detect, and so important for anyone with knowledge of …
$2.5 Million Verdict for Risperdal Victim
Our team of Risperdal attorneys recently reported on the Risperdal injury case ongoing in Philadelphia court. We are happy to announce that the jury just awarded the victim and his family with $2.5 million in damages. This case was brought by an autistic man, Austin Pledger, who was prescribed Risperdal when he was seven years old. At …
Risperdal Breast Growth Case Begins in Philadelphia
The popular antipsychotic Risperdal has been named in thousands of lawsuits throughout the country for a troubling side effect in young men. The drug, commonly prescribed to treat bipolar disorder, carries the risk of abnormal breast growth. Risperdal lawyers at Pintas & Mullins Law Firm explain these lawsuits and who may be eligible for compensation. One of …
$2 Billion Risperdal Deal to have No Effect on Breast Tissue Cases
In a drawn-out and highly publicized settlement, Johnson & Johnson’s Janssen Pharmaceuticals recently agreed to pay the government $2.2 billion for illegally marketing its anti-psychotic drug Risperdal. At the same time, a less-publicized but equally important lawsuit is being waged over Risperdal, and will be unaffected by the billion dollar settlement. Risperdal attorneys at Pintas & …
Settlement Reached in Risperdal Illegal Marketing Suit
In one of the largest health care fraud settlements in U.S. history, Johnson & Johnson recently agreed to pay $2.2 billion for illegally marketing the drugs Risperdal, Invega and Natrecor. Whistleblower attorneys at Pintas & Mullins Law Firm are glad to see another pharmaceutical company paying for its illegal, fraudulent, and harmful marketing ploys. The lawsuit was …
Drug Recall for Health Risk Due to Odor
Pharmaceutical giant Johnson & Johnson, already in legal trouble for illegally marketing its antipsychotic drug Risperdal, is now recalling 16,000 bottles of Risperdal and 24,000 bottles of its generic equivalent. The latest drug recall comes after two consumers noticed a strange, musty odor emanating from the products. Our drug recall attorneys are familiar with the …